Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy pens cannot go into your household recycling bin. Each pre-filled pen contains residual medicine, a needle, and a small electronic auto-inject mechanism in some formats — a combination that standard kerbside collection is not equipped to handle safely. Disposal is governed by UK medicines regulations and NHS sharps guidance, and the short answer is that your local pharmacy is the right first stop. Wegovy is a prescription-only medicine (semaglutide, made by Novo Nordisk), so a prescriber has already been involved in your care — and the people who dispensed your pens can usually advise on returning or disposing of them too.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Guidance from the NHS and medicines regulators is clear that used injection devices containing residual pharmaceutical product are classified as clinical waste, not domestic recyclable material. The NHS medicines page for semaglutide directs patients not to throw used pens into household rubbish or recycling, and the Wegovy Patient Information Leaflet (available via the eMC) repeats this prominently. The reasons are practical: a residual drop of semaglutide in landfill or a recycling stream poses an environmental risk, the exposed needle is a sharps hazard, and some Wegovy pen formats include a small spring mechanism that fragments during processing.
This is not unique to Wegovy. All pre-filled injection devices used in weight management share the same classification. The rule is consistent whether you have one pen to dispose of or the full set from a four-pen pack, every used pen needs the same treatment. If you want to understand how a four-pen pack works in terms of supply and dosing schedule, that detail is covered separately, but disposal is the same whichever format you received.
The safest immediate step once a pen is spent: replace the cap, do not resheath the needle manually, and place the pen in a sealed container until you can transfer it to an approved sharps bin or return it to a pharmacy.
Community pharmacies across England operate sharps return schemes under NHS commissioning, meaning most high-street pharmacies will accept your used Wegovy pens at no cost to you. You do not need an appointment; you can hand used pens over at the dispensing counter. Scotland, Wales, and Northern Ireland run parallel arrangements, your dispensing pharmacy is the right first call wherever you are in the UK.
A dedicated sharps container is worth having at home if you are on a long course of treatment. It lets you accumulate used pens safely between pharmacy visits, avoids any risk to household members handling the bin, and gives the pharmacist a sealed unit to take straight into their clinical waste stream. One litre is typically sufficient for a month or two of weekly injections. If you have questions about how to use your Wegovy pen correctly before disposal (including removing the needle cap) the technique guide covers that step by step.
Some GP practices also hold sharps bins for patient returns, particularly where a GP has been involved in prescribing under the NHS rollout. If you are unsure, a quick call ahead saves a wasted trip, especially if you are trying to get it done before collecting the children.
Novo Nordisk has developed a pen-recycling scheme (sometimes referred to as their device take-back or circular economy programme) aimed at recovering the plastic and metal components of used pens once the medicine residue has been safely neutralised. This is distinct from general sharps disposal: the aim is to divert the pen casing from incineration and into a reprocessing stream.
Availability in the UK is not universal. Enrolment and collection logistics depend on which region you are in and which pharmacy is dispensing your medicine. Novo Nordisk's own UK communications and your dispensing pharmacy are the most reliable source of current scheme details, these programmes are updated periodically and a content page cannot guarantee what is available at your postcode today.
If this kind of environmental consideration matters to you when choosing a provider, it is worth asking when you receive your prescription, and you can find a full explanation of how Wegovy pen recycling works and what the scheme covers in practice. You can read more about the broader picture of Wegovy pens in the UK, including pen formats and how the semaglutide device differs across doses. For context on storage before a pen is used, Wegovy storage guidance explains the refrigeration rules and the limited window at room temperature.
Responsible disposal is one small part of the wider picture of being on a regulated prescription medicine. The MHRA's Yellow Card scheme is the UK's mechanism for reporting any problems with medicines or medical devices (including pens that appear damaged or faulty before use) and it is open to patients as well as healthcare professionals.
The full Wegovy treatment guide covers eligibility, how semaglutide works, and the UK licensing picture in more detail, including the newly approved 7.2mg dose. If you are weighing up your options more broadly, the weight-loss treatment overview sets out what is licensed in the UK and how private prescribing through a regulated pharmacy differs from the NHS route. Our clinical team's approach to that is explained on the clinical team page.
If you are thinking about starting Wegovy and want to know whether you are eligible, a free consultation with one of our GPhC-registered prescribers is where that conversation begins. A real clinician reviews every application, your answers go to a person, not a filter. Start your free consultation at our treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.